Resilient Lifescience

Resilient Lifescience is a legitimate, high-potential medical device startup backed by over $3.9M in grant funding (NIH/NIDA, RK Mellon) as of late 2024. They are developing a wearable to automatically detect and reverse opioid overdoses, a solution with exceptional real-world utility. However, the project submission provided contained inaccurate data (claiming 'most people have used my product' and 'everyone' as the audience), which significantly impacted the Response Quality and Audience Reach scores. Despite the poor submission quality, the underlying project's verified traction and life-saving technology drive a strong score.